EULAT Eradicate GBC
Conditions: Gallbladder Cancer; Gallstone Disease Interventions: Other: None, observational study. Sponsors: Institut de canc érologie Strasbourg Europe; Heidelberg University Hospital (UKHD, Germany, Coordinator); Universidad Austral de Chile (UACH, Chile); Universidad de la Frontera (UFRO, Chile); Universidad Católica del Maule (UCM, Chile); Centre international de recherche sur le cancer (IARC, France); Universidad de Chile (UChile, Chile); Instituto Nacional de Enfermedades Neoplásicas (INEN, Peru); Universidad Mayor de San Simón (UMSS, Bolivia); Oslo University Hospital; Sanatorio el Carmen (Argentina); Pontificia...
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials
Diagnostic Innovations for Pediatric Tuberculosis in Bolivia
Conditions: Tuberculosis Interventions: Diagnostic Test: Quantiferon Gold; Diagnostic Test: HIV serology; Diagnostic Test: Respiratory secretion culture (sputum or gastric aspirate_; Diagnostic Test: Chest radiograph; Diagnostic Test: Lung ultrasound; Diagnostic Test: cell free DNA test Sponsors: Tulane University; Asociacion Benefica Prisma; Universidad Peruana Cayetano Heredia; Johns Hopkins Bloomberg School of Public Health Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2023 Category: Research Source Type: clinical trials
Efficacy of the Use of Silver Diamine Fluoride and Sodium Fluoride Varnish for the Treatment of Caries in Children
Condition: Dental Caries in Children Intervention: Combination Product: Silver diamine fluoride 38% followed by Sodium fluoride varnish 5% Sponsors: Universidad Mayor de San Simón; Universidad Privada del Valle, Sede Cochabamba; Industria Química Farmacéutica SIGMA CORP S.R.L. Cochabamba, Bolivia; NODK LLC, Oregón, EE. UU. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2022 Category: Research Source Type: clinical trials
Treatment of Mucosal Bolivian Leishmaniasis
Condition: Mucosal Leishmaniasis Interventions: Drug: Group 1: Miltefosine; Drug: Group 2: Pentavalent Antimony; Drug: Group 3: Liposomal amphotericin B Sponsors: Fundacion Nacional de Dermatologia; Hospital Dermatologico de Jorochito; Centro Nacional de Enfermedades Tropicales CENETROP; ABF Foundation for Medical Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 16, 2021 Category: Research Source Type: clinical trials
